The present invention relates to the use of agomelatine, or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, in obtaining medicaments intended for the treatment of Smith-Magenis syndrome.
Web www.patentalert.com
< Method and apparatus providing asynchronous neural stimulation
> Implantable medical lead with proximal retrieval wire
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT